Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5/5-HT2AR Antagonist (VVZ-2471) in a Randomized, Double-Blind, First-in-Human Study. - Bae S; Lee H; Song I; Kim J; Lee SR; Cho S; Yu KS; Chung JY (CNS drugs, 2025)